sepsis associates with GRK expression and inhibition of actin
assembly and tyrosine phosphorylation. Blood 2006;108:
2906–13.
[35] Souza GEP, Ferreira SH. Blockade by antimacrophage serum of
the migration of PMN neutrophils into the inflamed peritoneal
cavity. Agents Actions 1985;17:97–103.
[36] Santucci L, Fiorucci S, Giansanti M, Brunori PM, Di Matteo FM,
Morelli A. Pentoxifylline prevents indomethacin induced acute
gastric mucosal damage in rats: role of tumour necrosis factor
alpha. Gut 1994;35:909–15.
[37] Ferreira SH, Nakamura M, de Abreu Castro MS. The hyperalgesic
effects of prostacyclin and prostaglandin E2. Prostaglandins
1978;16:31–7.
[38] Ferreira SH, Zanin T, Lorenzetti BB, de Souza MZ, Medeiros
MC, Leme JG. Increased vascular permeability, oedema and
hyperalgesia caused by carrageenan in the rat's paw. Agents
Actions 1978;8:159.
[39] Ferreira SH, Lorenzetti BB, Bristow AF, Poole S. Interleukin-1
beta as a potent hyperalgesic agent antagonized by a tripeptide
analogue. Nature 1988;334:698–700.
[40] Ferreira SH, Lorenzetti BB, Poole S. Bradykinin initiates
cytokine-mediated inflammatory hyperalgesia. Br J Pharmacol
1993;110:1227–31.
[41] Tjolsen A, Berge OG, Hunskaar S, Rosland JH, Hole K. The
formalin test: an evaluation of the method. Pain 1992;51:5–17.
[42] Sharon N. Lectin-carbohydrate complexes of plants and animals:
an atomic view. Trends Biochem Sci 1993;18:221–6.
[43] Rudiger H, Gabius HJ. Plant lectins: occurrence, biochemistry,
functions and applications. Glycoconj J 2001;18:589–613.
[44] Burke-Gaffney A, Hellewell PG. Tumour necrosis factor-alpha-
induced ICAM-1 expression in human vascular endothelial and
lung epithelial cells: modulation by tyrosine kinase inhibitors. Br
J Pharmacol 1996;119:1149–58.
[45] Casale TB, Carolan EJ. Cytokine-induced sequential migration
of neutrophils through endothelium and epithelium. Inflamm Res
1999;48:22–7.
[46] Bombini G, Canetti C, Rocha FA, Cunha FQ. Tumour necrosis
factor-alpha mediates neutrophil migration to the knee synovial
cavity during immune inflammation. Eur J Pharmacol
2004;496:197–204.
[47] Smeets RL, Joosten LA, Arntz OJ, Bennink MB, Takahashi N,
Carlsen H, et al. Soluble interleukin-1 receptor accessory protein
ameliorates collagen-induced arthritis by a different mode of
action from that of interleukin-1 receptor antagonist. Arthritis
Rheum 2005;52:2202–11.
[48] Feldmann M, Pusey CD. Is there a role for TNF-alpha in anti-
neutrophil cytoplasmic antibody-associated vasculitis? Lessons
from other chronic inflammatory diseases. J Am Soc Nephrol
2006;17:1243–52.
[49] Gaudreault E, Stankova J, Rola-Pleszczynski M. Involvement of
leukotriene B4 receptor 1 signaling in platelet-activating factor-
mediated neutrophil degranulation and chemotaxis. Prostaglan-
dins Other Lipid Mediat 2005;75:25–34.
[50] Khandaker MH, Mitchell G, Xu L, Andrews JD, Singh R, Leung
H, et al. Metalloproteinases are involved in lipopolysaccharide-
and tumor necrosis factor-alpha-mediated regulation of CXCR1
and CXCR2 chemokine receptor expression. Blood 1999;93:
2173–85.
[51] Ramos CD, Canetti C, Souto JT, Silva JS, Hogaboam CM,
Ferreira SH, et al. MIP-1alpha[CCL3] acting on the CCR1 receptor
mediates neutrophil migration in immune inflammation via
sequential release of TNF-alpha and LTB4. J Leukoc Biol
2005;78:167–77.
[52] Ramos CD, Fernandes KS, Canetti C, Teixeira MM, Silva JS,
Cunha FQ. Neutrophil recruitment in immunized mice depends
on MIP-2 inducing the sequential release of MIP-1alpha, TNF-
alpha and LTB(4). Eur J Immunol 2006;36:2025–34.
[53] Belperio JA, Keane MP, Burdick MD, Londhe V, Xue YY, Li K,
et al. Critical role for CXCR2 and CXCR2 ligands during the
pathogenesis of ventilator-induced lung injury. J Clin Invest
2002;110:1703–16.
[54] Moreno SE, Alves-Filho JC, Rios-Santos F, Silva JS, Ferreira
SH, Cunha FQ, et al. Signaling via platelet-activating factor
receptors accounts for the impairment of neutrophil migration in
polymicrobial sepsis. J Immunol 2006;177:1264–71.
[55] Coelho MB, Desouza IA, Freire MG, Marangoni S, Antunes E,
Macedo ML. Neutrophil migration in mice induc ed by a
mannose-binding lectin isolated from Annona coriacea seeds.
Toxicon 2006;48:529–35.
[56] Pereira-da-Silva G, Moreno AN, Marques F, Oliver C, Célia-
Jamur M, Panunto-Castelo A, et al. Neutrophil activation induced
by the lectin KM+ involves binding to CXCR2. Biochim
Biophys Acta 2006;1760:86–94.
[57] Cunha FQ, Lorenzetti BB, Poole S, Ferreira SH. Interleukin-8 as
a mediator of sympathetic pain. Br J Pharmacol 1991;104:765–7.
[58] Poole S, Lorenzetti BB, Cunha JM, Cunha FQ, Ferreira SH.
Bradykinin B1 and B2 receptors, tumour necrosis factor alpha
and inflammatory hyperalgesia. Br J Pharmacol 1999;126:
649–56.
[59] Shibata M, Ohkubo T, Takahashi H, Inoki R. Modified formalin
test: characteristic biphasic pain response. Pain 1989;38:347–52.
[60] Hong Y, Abbott FV. Contribution of peripheral alpha 1A-
adrenoceptors to pain induced by formalin or by alpha-methyl-5-
hydroxytryptamine plus noradrenaline. Eur J Pharmacol 1996;301:
41–8.
[61] Jourdan D, Ardid D, Bardin L, Bardin M, Neuzeret D,
Lanphouthacoul L, et al. New automated method of pain scoring
in the formalin test in rats. Pain 1997;71:265–70.
[62] Hama A, Menzaghi F. Antagonist of nicotinic acetylcholine
receptors (nAChR) enhances formalin-induced nociception in
rats: tonic role of nAChRs in the control of pain following injury.
Brain Res 2001;888:102–6.
[63] Le Bars D, Gozariu M, Cadden SW. Animal models of nociception.
Pharmacol Rev 2001;53:597–652.
[64] Parada CA, Tambeli CH, Cunha FQ, Ferreira SH. The major role
of peripheral release of histamine and 5-hydroxytryptamine in
formalin-induced nociception. Neuroscience 2001;102:937–44.
[65] Verri Jr WA, Schivo IR, Cunha TM, Liew FY, Ferreira SH,
Cunha FQ. Interleukin-18 induces mechanical hypernociception
in rats via endothelin acting on ETB receptors in a morphine-
sensitive manner. J Pharmacol Exp Ther 2004;310:710–7.
[66] Santodomingo-Garzon T, Cunha TM, Verri Jr WA, Valério DA,
Parada CA, Poole S, et al. Atorvastatin inhibits inflammatory
hypernociception. Br J Pharmacol 2006;149:14–22.
[67] Vale ML, Cunha FQ, Brito GA, Benevides VM, Ferreira SH,
Poole S, et al. Anti-nociceptive effect of thalidomide on zymosan-
induced experimental articular incapacitation. Eur J Pharmacol
2006;536:309–17.
[68] Vale ML, Benevides VM, Sachs D, Brito GA, da Rocha FA,
Poole S, et al. Antihyperalgesic effect of pentoxifylline on
experimental inflammatory pain. Br J Pharmacol 2004;143:
833–44.
835M.H. Napimoga et al. / International Immunopharmacology 7 (2007) 824–835